Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Aging in men is influenced by genetics and lifestyle, leading to muscle loss, bone issues, and skin damage.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Early hair loss may indicate risk of insulin resistance.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.